Flumequine in the goat: pharmacokinetics after intravenous and intramuscular administration

Vet Res Commun. 2005 Nov;29(8):689-98. doi: 10.1007/s11259-005-3867-7.

Abstract

The pharmacokinetics of flumequine, administered intravenously and intramuscularly at a single dose of 20 mg/kg, was investigated in healthy goats. After intravenous injection, flumequine distributed rapidly (t1/2alpha = 0.87+/-0.15 h) but was eliminated slowly (t1/2beta = 7.12+/-1.27 h); mean clearance (Cl) and volume of distribution (Vdss) were 0.32+/-0.03 (L/(h x kg) and 1.22+/-029 (L/kg), respectively. After intramuscular administration, the peakserum concentration (Cmax = 7.40+/-0.5 microg/ml) was reached in about 1.5 h (Tmax) and bioavailability was about 93%. Estimated flumequine serum levels following repeated intramuscular administration of the aqueous suspension used in the study (7.23+/-0.7 microg/ml and 4.82+/-0.47 microg/ml at intervals of 8 and 12 h, respectively) indicated that to maintain serum levels above MIC values for susceptible bacteria a dosage regimen of 20 mg/kg every 12 h is necessary by the intramuscular route.

Publication types

  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Infective Agents / administration & dosage*
  • Anti-Infective Agents / pharmacokinetics*
  • Biological Availability
  • Cross-Over Studies
  • Female
  • Fluoroquinolones / administration & dosage*
  • Fluoroquinolones / pharmacokinetics*
  • Goats / metabolism*
  • Injections, Intramuscular / methods
  • Injections, Intramuscular / veterinary
  • Injections, Intravenous / methods
  • Injections, Intravenous / veterinary
  • Metabolic Clearance Rate / drug effects
  • Metabolic Clearance Rate / physiology

Substances

  • Anti-Infective Agents
  • Fluoroquinolones
  • flumequine